Citation Impact
Citing Papers
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Use and Abuse of HOMA Modeling
2004 Standout
Thiazolidinediones
2004 Standout
Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice
2003
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Development of Cu nanoflowers modified the flexible needle-type microelectrode and its application in continuous monitoring glucose in vivo
2018
Inflammation and metabolic disorders
2006 StandoutNature
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells
2003
The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes
2011
Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome
2005
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
IL‐23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin
2005
Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes
2009
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
2001 StandoutNature
Mitochondrial function in normal and diabetic β-cells
2001 Nature
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
2003
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
2005
Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty
2009
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Cushing's syndrome
2015 Standout
Intervention in autoimmunity: The potential of vitamin D receptor agonists
2005
Uric Acid and Cardiovascular Risk
2008 Standout
Mitochondrial toxicity and HIV therapy
2001
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Inflammation, stress, and diabetes
2005 Standout
AGA technical review on nonalcoholic fatty liver disease
2002
Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization Approach
2012
Cushing’s syndrome complicated by multiple opportunistic infections
1998
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Is HIV a Model of Accelerated or Accentuated Aging?
2013
Adverse effects of antiretroviral therapy
2000
Lipodystrophies: rare disorders causing metabolic syndrome
2004
Type 2 diabetes
2017 Standout
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
The diagnosis and management of monogenic diabetes in children and adolescents
2009
Type 1 diabetes
2013 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus
2005
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
2003
State of Telehealth
2016 Standout
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Normal Thyroid Thermogenesis but Reduced Viability and Adiposity in Mice Lacking the Mitochondrial Glycerol Phosphate Dehydrogenase
2002
A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity
2002 StandoutNobel
Geroscience: Linking Aging to Chronic Disease
2014 Standout
Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein
2007
CXCR3 ligands in disease and therapy
2014
Frailty in elderly people
2013 Standout
Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial
2013
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
2006
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Functional mapping of disease susceptibility loci using cell biology
2006 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Effect of Mitochondrial and/or Cytosolic Glycerol 3-Phosphate Dehydrogenase Overexpression on Glucose-Stimulated Insulin Secretion From MIN6 and HIT Cells
1996
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
A high carbohydrate diet does not induce hyperglycaemia in a mitochondrial glycerol-3-phosphate dehydrogenase-deficient mouse
2003
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Artificial Molecular Machines
2015 Standout
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
2003
Poly(ADP-ribose) (PAR) polymer is a death signal
2006 Standout
Body Habitus Changes and Metabolic Alterations in Protease Inhibitor–Naive HIV-1–Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors
2002
METABOLIC ENGINEERING WITH RECOMBINANT ADENOVIRUSES
1999
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Works of Ignacio Conget being referenced
Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with Lipodystrophy
2000
Essential pathogenic role of endogenous IL‐18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL‐18‐binding protein: Fc construct
2003
Lower rate of tumor necrosis factor-α −863A allele and higher concentration of tumor necrosis factor-α receptor 2 in first-degree relatives of subjects with type 2 diabetes
2003
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
2001
Uric acid concentration in subjects at risk of type 2 diabetes mellitus: Relationship to components of the metabolic syndrome
2002
Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C‐reactive protein in subjects with impaired fasting glucose
2003
Hexose metabolism in pancreatic islets. Regulation of aerobic glycolysis and pyruvate decarboxylation
1991
Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C
2001
High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients.
1998
The genetic abnormality in the beta cell determines the response to an oral glucose load
2002
Enzymatic, metabolic and secretory patterns in human islets of Type 2 (non-insulin-dependent) diabetic patients
1994
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
1999
Respiratory chain activity and mitochondrial DNA content of nonpurified and purified pancreatic islet cells
1997
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
2012
Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control
2006
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
2009
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial
2014
Interleukin-13 prevents autoimmune diabetes in NOD mice.
1999
Insulinotropic action of glutamic acid dimethyl ester
1994
[Lung adenocarcinoma and urticaria].
1987
Effects of nicotinamide and intravenous insulin therapy in newly diagnosed type 1 diabetes.
2000
Long-Term Effects of Roux-en-Y Gastric Bypass Surgery on Plasma Glucagon-Like Peptide-1 and Islet Function in Morbidly Obese Subjects
2008
Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial
2016
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice.
1999
Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
2002
Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
2001
Adult-Onset Atypical (Type 1) Diabetes
2004